Rivastigmine Hydrogen Tartrate contains not less than 98.0% and not more than 102.0% of C14H22N2O2˙C4H6O6 calculated on the dried basis.

共有 1 個藥物證書使用此成份

里曼提酒石酸鹽
Rivastigmine Hydrogen Tartrate

• 申請商: 鴻傑藥品有限公司
• 適應症: 輕度至中度阿滋海默氏病之失智症。
• 發證日期: 2013-02-19